Tag: Covaxin late-stage trial in India
RIO DE JANEIRO, BRAZIL - Bharat Biotech’s vaccine showed a 81% efficacy in preventing symptomatic COVID-19 in an interim analysis of a late-stage trial in India, it said on Wednesday, March 3rd, a major boost for the shot shunned...